Holen Sie sich die Stockscreener-App
0.8754
8.81%
-0.0846
Schlusskurs vom Vortag:
$0.96
Offen:
$0.96
24-Stunden-Volumen:
696.64K
Relative Volume:
0.67
Marktkapitalisierung:
$47.01M
Einnahmen:
$114.73M
Nettoeinkommen (Verlust:
$-140.94M
KGV:
-0.3172
EPS:
-2.76
Netto-Cashflow:
$-126.18M
1W Leistung:
-2.63%
1M Leistung:
+8.49%
6M Leistung:
+26.87%
1J Leistung:
-72.73%
1-Tages-Spanne:
$0.85
$0.97
1-Wochen-Bereich:
$0.8218
$1.08
52-Wochen-Spanne:
$0.435
$5.22
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Vergleichen Sie OM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
0.8754 | 47.01M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical projects $115M-$125M revenue in 2025 with focus on console growth and gross margin expansion - MSN
Outset Medical Q4 2024 Earnings Preview - MSN
Outset Medical Shines Amid Revenue Growth and Operational Gains - TipRanks
Leslie Trigg Sells 14,611 Shares of Outset Medical, Inc. (NASDAQ:OM) Stock - MarketBeat
Outset Medical (NASDAQ:OM) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Outset Medical (NASDAQ:OM) Issues Earnings Results - MarketBeat
Outset Medical stock rises on Street-beating Q4, 2025 guidance - Mass Device
Outset Medical, Inc. (NASDAQ:OM) Q4 2024 Earnings Call Transcript - Insider Monkey
Outset Medical Inc (OM) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Outset Medical earnings beat by $0.06, revenue topped estimates - Investing.com Australia
Outset Medical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Outset Medical Exceeds Revenue Guidance in 2024 - TipRanks
Outset Medical: Profitability Path Brightens - The Motley Fool
Outset Medical: Profitability Path Brightens - Nasdaq
Earnings call transcript: Outset Medical Q4 2024 beats EPS forecast, stock gains - Investing.com
Outset Medical general counsel sells $5,530 in stock By Investing.com - Investing.com South Africa
Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Outset Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Outset Medical's SVP Nash Marc sells shares for $3,783 - Investing.com
Outset Medical general counsel sells $5,530 in stock - Investing.com
Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results -February 19, 2025 at 04:04 pm EST - Marketscreener.com
Earnings To Watch: Outset Medical Inc (OM) Reports Q4 2024 Resul - GuruFocus.com
Earnings To Watch: Outset Medical Inc (OM) Reports Q4 2024 Result - Yahoo Finance
Outset Medical SVP sells $18,576 in common stock - MSN
Levi & Korsinsky Notifies Shareholders of Outset Medical, Inc.(OM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Outset Medical CFO Ahmed Nabeel sells $27,430 in stock - MSN
Class Action Filed Against Outset Medical, Inc. (OM) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical general counsel John Brottem sells $26,344 in stock - MSN
Outset Medical, Inc. Announces Board and Committee Changes -March 24, 2021 at 09:16 am EDT - Marketscreener.com
OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical plans $100M mixed shelf offering - MSN
Outset Medical Announces Resolution of Warning Letter - GlobeNewswire
Outset Medical resolves FDA warning letter - Mass Device
Outset Medical Announces Resolution Of Warning Letter -February 13, 2025 at 05:14 pm EST - Marketscreener.com
FDA clears Outset Medical of previous warning issues - Investing.com
Outset Medical Inc. (OM) Announces Resolution of Warning Letter - StreetInsider.com
FDA Clears Outset Medical: Major Regulatory Victory for Revolutionary Dialysis Tech - StockTitan
Outset Medical Inc. (OM) Files $100M Mixed Shelf - StreetInsider.com
OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
BTIG cuts Outset Medical target to $3, maintains Buy rating - MSN
Outset medical stock news: OM stock poised for growth amid transformation - Markets.com
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025 - The Manila Times
Outset Medical Q4 Earnings: Key Financial Updates Coming as Dialysis Tech Leader Reports - StockTitan
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Vanguard Group Inc Reduces Stake in Outset Medical Inc - GuruFocus.com
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Outset Medical Inc-Aktie (OM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nash Marc | SVP Operations and R&D |
Feb 18 '25 |
Sale |
0.90 |
4,204 |
3,784 |
200,764 |
| Brottem John L. | General Counsel |
Feb 18 '25 |
Sale |
0.90 |
6,145 |
5,530 |
175,043 |
| Ahmed Nabeel | Chief Financial Officer |
Feb 18 '25 |
Sale |
0.90 |
8,659 |
7,793 |
250,210 |
1.16%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):